Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA. Sattui SE, et al. Expert Rev Clin Immunol. 2020 Jul;16(7):659-666. doi: 10.1080/1744666X.2020.1792778. Epub 2020 Aug 11. Expert Rev Clin Immunol. 2020. PMID: 32620062 Free PMC article. Review.
The complement system in COVID-19: friend and foe?
Java A, Apicelli AJ, Liszewski MK, Coler-Reilly A, Atkinson JP, Kim AH, Kulkarni HS. Java A, et al. JCI Insight. 2020 Aug 6;5(15):e140711. doi: 10.1172/jci.insight.140711. JCI Insight. 2020. PMID: 32554923 Free PMC article. Review.
Hope on the Horizon: Novel Fungal Treatments in Development.
Rauseo AM, Coler-Reilly A, Larson L, Spec A. Rauseo AM, et al. Open Forum Infect Dis. 2020 Jan 12;7(2):ofaa016. doi: 10.1093/ofid/ofaa016. eCollection 2020 Feb. Open Forum Infect Dis. 2020. PMID: 32099843 Free PMC article. Review.
Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.
Yamauchi J, Coler-Reilly A, Sato T, Araya N, Yagishita N, Ando H, Kunitomo Y, Takahashi K, Tanaka Y, Shibagaki Y, Nishioka K, Nakajima T, Hasegawa Y, Utsunomiya A, Kimura K, Yamano Y. Yamauchi J, et al. J Infect Dis. 2015 Jan 15;211(2):238-48. doi: 10.1093/infdis/jiu438. Epub 2014 Aug 7. J Infect Dis. 2015. PMID: 25104771
Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.
Coler-Reilly ALG, Sato T, Matsuzaki T, Nakagawa M, Niino M, Nagai M, Nakamura T, Takenouchi N, Araya N, Yagishita N, Inoue E, Yamano Y. Coler-Reilly ALG, et al. Neurotherapeutics. 2017 Oct;14(4):1084-1094. doi: 10.1007/s13311-017-0533-z. Neurotherapeutics. 2017. PMID: 28536850 Free PMC article.
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y. Sato T, et al. N Engl J Med. 2018 Feb 8;378(6):529-538. doi: 10.1056/NEJMoa1704827. N Engl J Med. 2018. PMID: 29414279 Free article. Clinical Trial.
33 results